Business Wire: ERS Genomics and Aelian Biotechnology Announce CRISPR/Cas9 License Agreement Enabling Aelian's Unique Screening Platform
- #news
- #headline
Business Wire: ERS Genomics and Aelian Biotechnology Announce CRISPR/Cas9 License Agreement Enabling Aelian's Unique Screening Platform
Captured 2026-08-23 from Business Wire. The archived copy is preserved so this citation survives link rot.